Expert Q&As
Launching in EU - Q&A 8
What risk areas should we pay special attention to (pharmacovigilance, legal, compliance, etc.) when launching in Europe?
Access decades of experience
What’s Inside the Q&A:
Pharmacovigilance Systems
Uncover how Europe’s safety oversight demands transform the way you monitor, report, and protect patient outcomes.
Legal and Liability Frameworks
Explore the intersecting layers of EU law that reshape your approach to contracts, privacy, and product responsibility.
Compliance and Ethics Culture
See how embedding transparency and integrity from day one becomes your strongest shield against regulatory risk.
Reputation and Risk Management
Learn how strategic communication and preparedness safeguard both your market access and public trust.
Download our expert answer
Discover our latest news
Expert Q&As
Launching in EU - Q&A 1
Why is launching a drug in Europe different from launching in the US?
Expert Q&As
Launching in EU - Q&A 3
How to choose the right location for our European headquarters or hub?
Expert Q&As
Launching in EU - Q&A 2
How should we go about hiring and building a European presence?
